BAP18 acting as a novel peroxisome proliferator-activated receptor α co-regulator contributes to hepatocellular carcinoma progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BAP18 acting as a novel peroxisome proliferator-activated receptor α co-regulator contributes to hepatocellular carcinoma progression

Published:2024-02 Issue:2 Volume:1870 Page:166974
ISSN:0925-4439
Container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Author:

Liu Wei,Wang Shengli,Lin Lin,Zou Renlong,Sun Hongmiao,Zeng Kai,Wu Yi,Li Yiling,Shigeaki Kato,Wang Xiuxia,Wang Chunyu,Zhao Yue

Publisher

Elsevier BV

Subject

Molecular Biology,Molecular Medicine

Reference63 articles.

1. Cancer statistics;Siegel;CA Cancer J. Clin.,2022

2. The trends in incidence of primary liver cancer caused by specific etiologies: results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention;Liu;J. Hepatol.,2019

3. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015;C. Global Burden of Disease Liver Cancer;JAMA Oncol.,2017

4. The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma;Xia;EBioMedicine,2020

5. Lenvatinib for hepatocellular carcinoma: a literature review;Hatanaka;Pharmaceuticals (Basel),2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP